An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is evaluate effects of TRAVATAN® versus LUMIGAN® on intraocular
pressure (IOP) and ocular surface and inflammatory biomarkers.